Common treatment of polycystic ovarian syndrome and major depressive disorder: case report and review.

Current drug targets. Immune, endocrine and metabolic disorders

Volumn 2, Issue 1, 2002, Pages 97-102

  Rasgon, N L ^a   Carter, M S ^a   Elman, S ^a   Bauer, M ^a   Love, M ^a   Korenman, S G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; FLUOXETINE; METFORMIN; SPIRONOLACTONE;

ADULT; CASE REPORT; DRUG COMBINATION; FEMALE; HUMAN; MAJOR DEPRESSION; OVARY POLYCYSTIC DISEASE; REVIEW;

ADULT; ALDOSTERONE ANTAGONISTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; FEMALE; FLUOXETINE; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; POLYCYSTIC OVARY SYNDROME; SPIRONOLACTONE;

EID: 0036528283     PISSN: 15680088     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568005310202010097     Document Type: Review

References (64)